ICD-10 Code E88.09: Hypoalbuminemia (Other Disorders of Plasma-Protein Metabolism)

Key Takeaways

ICD-10 code E88.09 classifies hypoalbuminemia under metabolic disorders

Serum albumin below 3.5 g/dL typically indicates hypoalbuminemia

Documentation requires both lab values and clinical significance

Code excludes familial hypalbuminemia (E88.01) and neonatal cases

Assign code only when hypoalbuminemia drives clinical decision-making

Understanding ICD-10 Code E88.09: Hypoalbuminemia

ICD-10 code E88.09 represents hypoalbuminemia, a condition characterised by abnormally low serum albumin levels. This diagnostic code falls under category E88, which encompasses other disorders of plasma-protein metabolism not elsewhere classified. Hypoalbuminemia occurs when serum albumin drops below normal reference ranges, typically defined as less than 3.5 g/dL, though laboratory thresholds may vary.

Healthcare providers use ICD-10 code E88.09 when documenting patients presenting with low albumin levels that cannot be attributed to familial hypoalbuminemia or other specifically coded conditions. The code serves as a billing and documentation tool, linking laboratory findings to clinical decision-making. Proper coding requires understanding when hypoalbuminemia represents a primary diagnosis versus a secondary finding.

Clinics managing patients with metabolic disorders benefit from digital documentation systems that streamline laboratory result tracking and coding accuracy. Modern practice management platforms help ensure albumin levels are properly recorded alongside relevant clinical context, supporting both patient care and billing compliance.

What Is ICD-10 Code E88.09?

ICD-10 code E88.09 classifies hypoalbuminemia within the broader category of metabolic disorders affecting plasma proteins. The code structure reflects its position in the ICD-10-CM hierarchy. E88 denotes “Other disorders of metabolism,” with E88.0 specifically addressing disorders of plasma-protein metabolism. E88.09 serves as the “other specified” code within this subcategory, distinguishing it from E88.01, which codes for familial hypalbuminemia.

The CDC’s ICD-10-CM classification system defines hypoalbuminemia as a measurable decrease in serum albumin concentration. Albumin, synthesised in the liver, maintains oncotic pressure, transports hormones and drugs, and serves as a nutritional marker. When production decreases or loss increases, clinical consequences emerge.

This diagnostic code captures acquired hypoalbuminemia stemming from multiple aetiologies: hepatic dysfunction, renal protein loss, malnutrition, inflammatory states, or dilutional changes. Providers assign E88.09 when laboratory evidence confirms low albumin and clinical assessment indicates the finding drives treatment decisions. The code does not apply to transient or physiologically insignificant variations.

Distinguishing ICD-10 code E88.09 from related codes requires clinical judgment. Familial hypoalbuminemia, a genetic condition, receives code E88.01. Neonatal hypoalbuminemia belongs to separate perinatal codes. When hypoalbuminemia results from specific conditions like cirrhosis or nephrotic syndrome, those primary diagnoses take precedence, with E88.09 serving as an additional code only when the albumin level itself necessitates separate clinical attention.

Practices managing metabolic disorders can improve billing accuracy and claims management by ensuring staff understand code exclusions and documentation requirements before submitting claims.

Clinical Definition and Diagnostic Criteria

Hypoalbuminemia is clinically defined as serum albumin concentration below the laboratory’s established reference range, commonly cited as less than 3.5 g/dL. Laboratory methods vary, so providers must reference the specific facility’s normal values. Severity classifications often categorise mild hypoalbuminemia as 3.-3.5 g/dL, moderate as 2.5-2.9 g/dL, and severe as below 2.5 g/dL.

Diagnosis requires laboratory confirmation through serum albumin measurement, typically performed via bromocresol green or bromocresol purple methods. Single measurements may not suffice. Serial testing establishes trends and rules out laboratory error or transient changes. Providers assess albumin alongside total protein, albumin-to-globulin ratio, and markers of inflammation such as C-reactive protein.

Clinical presentation varies with severity and underlying cause. Mild hypoalbuminemia may remain asymptomatic. Moderate to severe cases present with peripheral oedema, ascites, pleural effusions, or generalised anasarca. Reduced oncotic pressure shifts fluid from vascular spaces to interstitial tissues. Patients may report weight gain despite poor nutritional intake, reflecting fluid accumulation rather than tissue mass.

Diagnostic workup extends beyond albumin measurement. Providers investigate underlying aetiologies through liver function tests, renal function panels, urinalysis for proteinuria, nutritional assessment, and inflammatory markers. A 24-hour urine protein collection quantifies renal losses. Imaging may reveal ascites or effusions. The goal is identifying whether hypoalbuminemia stems from decreased production, increased loss, or redistribution.

Documentation must specify the albumin value, the laboratory’s reference range, clinical symptoms attributable to hypoalbuminemia, and any identified underlying conditions. This detail supports medical necessity for assigning ICD-10 code E88.09 and justifies interventions such as albumin infusions, nutritional supplementation, or treatment of causative disorders.

ICD-10 Code E88.09 Documentation Requirements

Accurate coding of hypoalbuminemia requires comprehensive documentation linking laboratory findings to clinical significance. Payers scrutinise claims for E88.09, expecting clear evidence that the diagnosis influenced patient management. Documentation must demonstrate medical necessity, not simply report an incidental laboratory finding.

Essential documentation elements include the date of albumin testing, the specific albumin value with units, the laboratory’s reference range, and clinical context. Providers should document symptoms such as oedema, ascites, or unexplained weight changes. Note whether hypoalbuminemia is newly identified or represents a chronic condition. Record any previous albumin levels to establish trends.

The clinical note must explain why the provider assessed albumin. Was it part of a metabolic panel for surgical clearance, nutritional evaluation in a patient with weight loss, or monitoring for nephrotic syndrome? The indication for testing supports the diagnosis’s relevance. Document how hypoalbuminemia affected clinical decisions: ordering additional diagnostics, initiating albumin infusions, modifying diuretic therapy, or adjusting nutritional support.

When hypoalbuminemia coexists with other conditions, clarify relationships in documentation. If a patient with cirrhosis develops severe hypoalbuminemia requiring albumin replacement, both codes apply. The cirrhosis code reflects the underlying disease, while E88.09 captures the metabolic complication driving a specific intervention. If albumin is mildly low but does not alter management, coding hypoalbuminemia separately lacks justification.

Practices handling complex metabolic cases benefit from clinical documentation tools that capture structured data points, ensuring coders receive complete information for accurate ICD-10 code E88.09 assignment.

Supporting Laboratory Data

Laboratory documentation extends beyond the albumin value itself. Include total protein to calculate the albumin-to-globulin ratio. Low albumin with normal total protein suggests increased globulin production, often seen in inflammatory or infectious states. Low albumin with low total protein points toward protein-losing processes or malnutrition.

Document concurrent liver function tests if hepatic synthesis impairment is suspected. Bilirubin, alkaline phosphatase, and transaminases help identify liver disease. Prothrombin time reflects hepatic synthetic function alongside albumin. Renal function tests, including serum creatinine and blood urea nitrogen, assess whether protein loss occurs via renal routes. Urinalysis showing proteinuria supports nephrotic syndrome or glomerular disease.

Inflammatory markers such as C-reactive protein or erythrocyte sedimentation rate provide context. Hypoalbuminemia during acute inflammation represents a negative acute-phase response, with cytokines suppressing albumin synthesis. This differs mechanistically from chronic liver disease or malnutrition. Documenting inflammatory markers clarifies whether hypoalbuminemia is reactive or due to primary metabolic dysfunction.

Coding Guidelines and Exclusions for ICD-10 Code E88.09

ICD-10 code E88.09 follows specific coding rules that prevent misclassification and ensure accurate billing. The code applies only when hypoalbuminemia represents a distinct clinical entity requiring separate documentation and intervention. Coders must distinguish E88.09 from related conditions that receive different codes or no separate code at all.

The primary exclusion is familial hypoalbuminemia, coded as E88.01. This genetic condition, characterised by congenital low albumin without clinical symptoms, differs fundamentally from acquired hypoalbuminemia. Family history, age of onset, and absence of secondary causes guide differentiation. Neonatal hypoalbuminemia, when unrelated to familial forms or specific perinatal conditions, falls under perinatal coding categories rather than E88.09.

When hypoalbuminemia results directly from a specified condition, code the underlying disease first. For cirrhosis with hypoalbuminemia, assign the cirrhosis code as the principal diagnosis. E88.09 may serve as an additional code if the albumin level itself prompted specific interventions like albumin infusion. If hypoalbuminemia is an expected finding not influencing treatment, coding it separately is inappropriate.

Nephrotic syndrome presents a similar scenario. The nephrotic syndrome code encompasses proteinuria, oedema, and hypoalbuminemia as a triad. Assigning E88.09 in addition to nephrotic syndrome codes may be redundant unless the hypoalbuminemia severity necessitates distinct therapeutic measures beyond nephrotic syndrome management. Clinical documentation must justify separate coding.

Malnutrition-related hypoalbuminemia requires careful coding. Protein-energy malnutrition codes exist within the ICD-10 system. If hypoalbuminemia stems from documented malnutrition, use the appropriate malnutrition code. E88.09 applies when albumin depletion exceeds expected malnutrition findings or when albumin replacement therapy is administered beyond standard nutritional support.

Providers working with integrative medicine workflows often encounter patients with multiple metabolic imbalances. Clear coding hierarchies prevent claim denials by ensuring primary diagnoses reflect the most clinically significant conditions.

Sequencing and Principal Diagnosis Considerations

Code sequencing affects reimbursement and reflects the clinical encounter’s focus. When hypoalbuminemia is the reason for the visit, such as a patient referred for low albumin evaluation, E88.09 may serve as the principal diagnosis. More commonly, hypoalbuminemia is a finding within a broader clinical presentation, positioned as a secondary diagnosis.

In inpatient settings, the principal diagnosis is the condition established after study to be chiefly responsible for the admission. If a patient is admitted for management of decompensated cirrhosis and hypoalbuminemia is addressed during the stay, cirrhosis is the principal diagnosis. E88.09 ranks as an additional diagnosis, coded only if it influenced resource utilisation or treatment complexity.

Outpatient coding follows similar logic but with less stringent principal diagnosis rules. The first-listed diagnosis reflects the primary reason for the encounter. If a patient presents for albumin infusion due to documented hypoalbuminemia, E88.09 may be the first-listed code. If the visit addresses chronic kidney disease with incidental hypoalbuminemia noted in labs but not treated, chronic kidney disease takes precedence.

Billing and Reimbursement Considerations

Billing for ICD-10 code E88.09 requires demonstrating medical necessity for both the diagnosis and any associated interventions. Payers assess whether hypoalbuminemia documentation justifies the services provided, including laboratory testing, imaging, albumin infusions, or specialist consultations. Without clear linkage between the diagnosis and treatment, claims face denial or downcoding.

Albumin infusion, often administered to patients with severe hypoalbuminemia, must be supported by clinical indications such as symptomatic oedema unresponsive to diuretics, hypovolemia despite fluid administration, or pre-procedural correction before surgery. Documentation should specify the albumin dose, infusion rate, and clinical response. Payers scrutinise albumin use due to cost and concerns about inappropriate utilisation in non-approved indications.

Laboratory testing for hypoalbuminemia typically includes serum albumin measurement as part of a comprehensive metabolic panel or basic metabolic panel. These panels have established reimbursement rates. Repeat testing requires documentation of clinical changes or monitoring needs. Frequent albumin measurements without documented justification may trigger payer audits questioning medical necessity.

When hypoalbuminemia drives diagnostic workups, code E88.09 links to additional services such as liver imaging, renal ultrasound, or 24-hour urine protein collection. The diagnosis supports medical necessity for these tests, provided documentation explains why they were ordered. For example, ultrasound to assess cirrhosis in a patient with low albumin and elevated liver enzymes is justified; ordering the same test without documented liver abnormalities is not.

Practices managing metabolic disorders can streamline claims submission and follow-up by ensuring documentation supports each billed service before claims leave the office. Pre-submission audits reduce denials.

Common Billing Errors to Avoid

Several billing pitfalls surround ICD-10 code E88.09. Coding hypoalbuminemia without laboratory documentation is the most common error. Claims must include the albumin value and reference range in supporting documentation, even if not on the claim form itself. Payers may request records during audits.

Another error is coding E88.09 when albumin is only marginally below normal and the patient is asymptomatic. Payers expect clinical significance: symptoms, complications, or interventions directly related to the low albumin. Incidental findings on routine panels without clinical correlation do not justify separate coding.

Using E88.09 alongside nephrotic syndrome or cirrhosis codes without documenting distinct hypoalbuminemia management invites denials. If albumin infusion or specific albumin-targeted therapy occurred, document this clearly. If hypoalbuminemia is an expected component of the primary diagnosis and no separate intervention was performed, omit E88.09.

Failure to code underlying conditions when they exist is equally problematic. A patient with liver disease and low albumin should have both the liver disease code and E88.09 when appropriate. Coding only E88.09 misrepresents the clinical scenario and may result in incomplete reimbursement for complexity.

Simplify Metabolic Disorder Documentation

Pabau's clinical documentation tools help capture the laboratory values, clinical context, and treatment decisions that support accurate ICD-10 coding for hypoalbuminemia and other metabolic conditions.

Book a demo

Clinical Context: Causes and Associations

Hypoalbuminemia arises from diverse aetiologies affecting albumin synthesis, distribution, or loss. Understanding the underlying causes informs both diagnosis and coding. While ICD-10 code E88.09 captures the metabolic consequence, identifying the root cause guides treatment and determines whether additional codes apply.

Hepatic dysfunction represents a major cause. The liver synthesises albumin; chronic liver diseases like cirrhosis reduce production. Acute liver failure also impairs synthesis, though hypoalbuminemia may be less pronounced in acute settings. Documentation should specify the liver condition type, severity, and whether albumin levels correlate with disease progression.

Renal protein loss through nephrotic syndrome, glomerulonephritis, or diabetic nephropathy causes hypoalbuminemia by excreting albumin faster than the liver can replace it. Urinalysis showing significant proteinuria and 24-hour urine protein quantification support renal aetiologies. Coding requires both the renal diagnosis and, when clinically significant, E88.09.

Malnutrition, particularly protein-energy malnutrition, decreases albumin synthesis due to insufficient amino acid substrates. Starvation, malabsorption disorders, and chronic inflammatory bowel disease contribute. Albumin’s long half-life (approximately 20 days) means hypoalbuminemia develops gradually in nutritional deficiencies. Rapid declines suggest other mechanisms.

Inflammatory states suppress albumin synthesis through cytokine-mediated pathways. Sepsis, burns, trauma, and autoimmune diseases cause redistribution from vascular to interstitial spaces and reduced hepatic production. In these contexts, hypoalbuminemia correlates with inflammation severity and often resolves as inflammation subsides.

Protein-losing enteropathy, where intestinal mucosa allows protein leakage into the gut lumen, causes albumin loss. This occurs in inflammatory bowel disease, coeliac disease, and certain gastric conditions. Diagnosis may require specialised testing like fecal alpha-1 antitrypsin clearance.

Providers managing functional medicine cases often assess multiple contributing factors simultaneously, requiring comprehensive documentation to support both primary diagnoses and secondary metabolic codes.

Dilutional Hypoalbuminemia

Dilutional hypoalbuminemia occurs when extracellular fluid expansion lowers albumin concentration without true albumin depletion. Heart failure, renal failure with fluid overload, and excessive intravenous fluid administration cause this phenomenon. Total body albumin may be normal or even elevated, but concentration drops due to increased plasma volume.

Distinguishing dilutional from true hypoalbuminemia affects coding. If albumin concentration is low solely due to fluid overload and no albumin-specific intervention is performed, coding E88.09 may not be appropriate. The primary condition, such as congestive heart failure, captures the clinical scenario. If albumin infusion is given to address oncotic pressure despite dilutional aetiology, documentation must justify this decision for E88.09 coding to be supported.

Related ICD-10 Codes and Differential Diagnosis

Several ICD-10 codes overlap with or relate to E88.09, requiring careful differentiation. Familial hypoalbuminemia (E88.01) is the closest code, distinguished by genetic aetiology, family history, and absence of acquired causes. E88.01 typically presents in infancy or early childhood, with albumin levels stable over time and no associated clinical symptoms.

Other plasma-protein metabolism disorders within the E88 category include E88.1 (alpha-1 antitrypsin deficiency), E88.2 (lipomatosis), and E88.3 (tumor lysis syndrome). These conditions affect different proteins or metabolic pathways. E88.9 serves as an unspecified code for metabolic disorders when documentation lacks detail for more specific coding.

Protein-energy malnutrition codes (E40-E46) capture nutritional deficiencies that may cause hypoalbuminemia. Kwashiorkor (E40), marasmus (E41), and severe protein-calorie malnutrition (E43) all feature low albumin. When malnutrition is documented as the cause, these codes take precedence. E88.09 may be added if hypoalbuminemia severity exceeds expected malnutrition findings or requires specific intervention.

Liver disease codes within the K70-K77 range include cirrhosis, hepatic failure, and chronic hepatitis. These conditions often cause hypoalbuminemia as hepatic synthetic function declines. Code the liver disease as the primary diagnosis. Add E88.09 only when hypoalbuminemia itself drives specific clinical actions, such as albumin infusion before paracentesis.

Nephrotic syndrome (N04) encompasses proteinuria, hypoalbuminemia, hyperlipidaemia, and oedema. The nephrotic syndrome code inherently includes hypoalbuminemia as a defining feature. Additional E88.09 coding is redundant unless albumin levels are exceptionally low or require targeted therapy beyond standard nephrotic syndrome management.

For comprehensive patient management across multiple conditions, integrated clinical records allow providers to track primary diagnoses alongside metabolic complications, ensuring accurate code assignment at each encounter.

Treatment and Management Documentation

Documenting treatment for hypoalbuminemia strengthens medical necessity for ICD-10 code E88.09. Interventions range from addressing underlying causes to direct albumin replacement. Clinical notes must specify treatment rationale, modalities employed, and outcomes achieved.

Albumin infusion represents the most direct intervention. Documentation should include the indication (e.g., symptomatic oedema, pre-procedural correction, hypovolemia despite crystalloid), dose administered (typically 25% albumin at 12.5-50 grams), infusion rate, and monitoring for adverse reactions. Post-infusion assessment, including repeat albumin levels and symptom improvement, supports ongoing treatment necessity.

Nutritional support addresses hypoalbuminemia from malnutrition or inadequate intake. High-protein diets, enteral nutrition, or parenteral nutrition may be employed. Document protein targets, caloric goals, and dietitian involvement. Serial albumin measurements demonstrate whether nutritional interventions are effective. If albumin fails to improve despite adequate nutrition, this suggests non-nutritional aetiologies requiring further investigation.

Treating underlying conditions forms the cornerstone of hypoalbuminemia management. Optimising liver disease with medications, managing nephrotic syndrome with immunosuppressants, or controlling inflammation with targeted therapies addresses root causes. Documentation should link interventions to albumin trends, showing whether treating the primary condition improves albumin levels.

Diuretic management in patients with hypoalbuminemia and oedema requires careful documentation. Hypoalbuminemia reduces oncotic pressure, making diuretics less effective. Combining diuretics with albumin infusions may be necessary. Document the clinical reasoning for this combination, as payers may question albumin use in patients already receiving diuretics.

Monitoring and Follow-Up

Longitudinal documentation demonstrates whether hypoalbuminemia resolves, persists, or worsens. Establish a monitoring schedule based on severity and underlying cause. Severe hypoalbuminemia (below 2.5 g/dL) may warrant weekly monitoring until stabilised. Mild, chronic hypoalbuminemia might be assessed monthly or quarterly.

Document each follow-up visit’s findings: current albumin level, symptoms (presence or absence of oedema, ascites), weight trends, and any treatment adjustments. Note whether interventions achieved expected outcomes. Persistent hypoalbuminemia despite appropriate treatment suggests incomplete diagnosis or refractory underlying disease, justifying continued investigation and coding.

Common Documentation Pitfalls

Documentation errors compromise coding accuracy and billing success. Recognising common pitfalls helps providers avoid claim denials and ensure compliant documentation for ICD-10 code E88.09.

The most frequent error is documenting albumin levels without clinical context. A laboratory report showing low albumin does not, by itself, justify E88.09 coding. Clinical notes must explain why the albumin level matters: symptoms it explains, decisions it influenced, or interventions it prompted. Without this linkage, coders cannot determine whether hypoalbuminemia constitutes a billable diagnosis.

Failing to document the laboratory reference range creates ambiguity. Different laboratories use different methods and reference values. An albumin of 3.4 g/dL might be low in one lab and normal in another. Always include the lab’s reference range to establish that the value is truly abnormal.

Omitting underlying conditions when they are known leads to incomplete coding. A patient with documented cirrhosis and hypoalbuminemia should have both conditions coded if both are addressed during the encounter. Coding only E88.09 misrepresents the clinical complexity and may result in inadequate reimbursement.

Conversely, coding E88.09 when it adds no clinical value inflates the problem list unnecessarily. If albumin is 3.4 g/dL (just below 3.5 g/dL), the patient has no symptoms, and no treatment is planned, coding hypoalbuminemia may not be appropriate. The diagnosis should influence patient care to warrant coding.

Inadequate documentation of treatment rationale weakens medical necessity claims. If albumin infusion is administered, the clinical note must explain why. “Low albumin” is insufficient justification. Document symptoms such as refractory oedema, planned paracentesis in a cirrhotic patient, or pre-surgical optimisation. This detail supports both the intervention and the diagnosis.

For practices managing complex coding scenarios, compliance management tools help standardise documentation practices and flag incomplete records before claim submission.

Expert Coding Tips for ICD-10 Code E88.09

Expert Picks

Need structured metabolic disorder documentation? Digital Forms Software enables standardised capture of albumin levels, clinical symptoms, and treatment rationale in a format that supports accurate E88.09 coding.

Managing patients across multiple chronic conditions? Client Record Management tracks diagnosis relationships, ensuring primary conditions and secondary metabolic codes are appropriately linked in clinical documentation.

Looking to reduce billing errors in metabolic coding? Claims Management Software flags incomplete documentation before submission, improving first-pass claim acceptance rates for complex diagnoses.

Conclusion

ICD-10 code E88.09 serves as a critical tool for documenting hypoalbuminemia when it represents a clinically significant metabolic disorder requiring intervention. Accurate coding depends on comprehensive documentation linking laboratory findings to clinical symptoms, underlying causes, and treatment decisions. Providers must distinguish E88.09 from familial forms, neonatal conditions, and hypoalbuminemia embedded within other diagnoses such as cirrhosis or nephrotic syndrome.

Successful billing requires demonstrating medical necessity through detailed clinical notes. Document albumin values with reference ranges, describe symptoms attributable to hypoalbuminemia, specify interventions performed, and track clinical responses. When hypoalbuminemia coexists with other conditions, clarify whether it necessitates separate clinical attention or is an expected component of the primary diagnosis.

By following these documentation and coding guidelines, healthcare providers ensure compliant claims submission, reduce denial rates, and accurately represent the complexity of patients presenting with metabolic disorders affecting plasma proteins. Proper use of ICD-10 code E88.09 supports both clinical care quality and financial sustainability.

Frequently Asked Questions